about
Current best practice in the management of hypertensive disorders in pregnancyA computational model of the circulating renin-angiotensin system and blood pressure regulation.Prevention And Treatment of Hypertension With Algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertensionRationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic.Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trialAdipose tissue (P)RR regulates insulin sensitivity, fat mass and body weight.Angiotensin inhibition and longevity: a question of hydration.Improving treatment adherence to antihypertensive therapy: the role of single-pill combinations.Pharmacological interventions into the renin-angiotensin system with ACE inhibitors and angiotensin II receptor antagonists: effects beyond blood pressure lowering.The Pharmacogenomic and Metabolomic Predictors of ACE Inhibitor and Angiotensin II Receptor Blocker Effectiveness and Safety.Antihypertensive response to thiazide diuretic or angiotensin receptor blocker in elderly hypertensives is not influenced by pretreatment plasma renin activity.Plasma renin activity in patients with heart failure and reduced ejection fraction on optimal medical therapy.Safety and efficacy of olmesartan: an observational pooled-analysis of 156,682 hypertensive patients.Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies.
P2860
Q26739585-B871CB82-5ECF-4107-8F0C-AF6FFDF14ED4Q33648850-A206BB17-BA25-474E-A82D-DDA248EFF80BQ35959952-896D2646-81ED-4316-859D-BE763B44F825Q36058755-25002D46-2C71-4B3F-A21D-A8AEE452D650Q36305422-8E992A64-5DA8-4FC9-B29A-303D6B0DD4B1Q37279023-C2EA9F64-AB32-4777-9E6E-37B8C9A48F64Q37821796-180CE569-055A-4803-9BF5-25C0239F0A4FQ37973403-0790BED0-DBD3-433D-A1DE-D53846274572Q38819507-4398E4B0-61C2-424A-98A6-9FA90DC03E4FQ39456476-B8512846-371B-4B39-B45D-04A665E8623DQ44430217-F03739FE-8880-4DB4-A80C-A953E16DEF47Q47898606-A863D0E7-2EAF-4A5B-A931-99735DEC98F3Q52899014-37D86AC9-6276-486D-96C8-84EEF1D89952Q53830197-C3A3B10B-ECB2-4ABB-8834-29045C235CEE
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Renin: friend or foe?
@ast
Renin: friend or foe?
@en
type
label
Renin: friend or foe?
@ast
Renin: friend or foe?
@en
prefLabel
Renin: friend or foe?
@ast
Renin: friend or foe?
@en
P2860
P356
P1433
P1476
Renin: friend or foe?
@en
P2093
Morris J Brown
P2860
P304
P356
10.1136/HRT.2006.107706
P407
P577
2007-05-08T00:00:00Z